In this report, the study analysis was given on a worldwide scale, for instance, present and traditional Radiopharmaceuticals in Nuclear Medicinegrowth analysis, competitive analysis, and also the growth prospects of the central regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from sales, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of sales, revenue and price.
The global Radiopharmaceuticals in Nuclear Medicine market was valued at USD xxx million in 2019, and it is expected to reach a value of USD xxx million by 2026, at a CAGR of xx% over the forecast period 2021-2026. Correspondingly, the forecast analysis of Radiopharmaceuticals in Nuclear Medicine industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the sales and revenue data in each of the sub-segments.
At the upcoming section, this report discusses industrial policy, economic environment, in addition to the fabrication processes and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine in these regions, from 2014 to 2026 (forecast), covering
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- South America (Brazil, Argentina, Columbia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Radiopharmaceuticals in Nuclear Medicine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
- Bracco Imaging S.P.A.
- Cambridge Isotope Laboratories, Inc.
- Cardinal Health, Inc.
- Covidien, Plc
- Eczacibasi-Monrol
- Fujifilm Holdings Corporation
- GE Healthcare (Subsidiary Of General Electric Company)
- IBA Group
- Isotec, Inc. (Sigma-Aldrich)
- Lantheus Medical Imaging, Inc.
- Nordion, Inc.
- Ntp Radioisotopes (Pty), Ltd.
- Siemens Healthcare (Subsidiary Of Siemens AG)
- Taiyo Nippon Sanso Corporation
- Urenco Limited
- Rotem Industries, Ltd., Inc.
- Australian Nuclear Association And Technology Organization (ANSTO)
- Board of Radiation And Isotope Technology (BRIT)
- Institute of Atomic Energy Polatom Radioisotope Centre
- Institute of Isotopes Co., Ltd.
- Institute Of Radioelement (IRE)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
- Diagnostic Radiopharmaceuticals
- Therapy Radiopharmaceuticals
- Enriched Stable Isotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine for each application, including
- Diagnostic Application
- Therapeutic Application
- Research
- Pharmaceutical
- Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Radiopharmaceuticals in Nuclear Medicine Market by Manufacturers, Regions, Type and Application, Forecast to 2025
Table of Contents
Global Radiopharmaceuticals in Nuclear Medicine Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Radiopharmaceuticals in Nuclear Medicine Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Therapy Radiopharmaceuticals Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Enriched Stable Isotopes Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Radiopharmaceuticals in Nuclear Medicine Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Radiopharmaceuticals in Nuclear Medicine Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Radiopharmaceuticals in Nuclear Medicine Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Radiopharmaceuticals in Nuclear Medicine Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Radiopharmaceuticals in Nuclear Medicine Market Assessment by Type
8.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Assessment by Application (Consumption and Market Share)
8.2 North America Radiopharmaceuticals in Nuclear Medicine Market Assessment by Application (Consumption and Market Share)
8.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Assessment by Application (Consumption and Market Share)
8.4 South America Radiopharmaceuticals in Nuclear Medicine Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Bracco Imaging S.P.A.
9.1.1 Bracco Imaging S.P.A. Profiles
9.1.2 Bracco Imaging S.P.A. Product Portfolio
9.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Business Performance
9.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Business Development and Market Status
9.2 Cambridge Isotope Laboratories, Inc.
9.2.1 Cambridge Isotope Laboratories, Inc. Profiles
9.2.2 Cambridge Isotope Laboratories, Inc. Product Portfolio
9.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Business Performance
9.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Business Development and Market Status
9.3 Cardinal Health, Inc.
9.3.1 Cardinal Health, Inc. Profiles
9.3.2 Cardinal Health, Inc. Product Portfolio
9.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Business Performance
9.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Business Development and Market Status
9.4 Covidien, Plc
9.4.1 Covidien, Plc Profiles
9.4.2 Covidien, Plc Product Portfolio
9.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Business Performance
9.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Business Development and Market Status
9.5 Eczacibasi-Monrol
9.5.1 Eczacibasi-Monrol Profiles
9.5.2 Eczacibasi-Monrol Product Portfolio
9.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Business Performance
9.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Business Development and Market Status
9.6 Fujifilm Holdings Corporation
9.6.1 Fujifilm Holdings Corporation Profiles
9.6.2 Fujifilm Holdings Corporation Product Portfolio
9.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Business Performance
9.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Business Development and Market Status
9.7 GE Healthcare (Subsidiary Of General Electric Company)
9.7.1 GE Healthcare (Subsidiary Of General Electric Company) Profiles
9.7.2 GE Healthcare (Subsidiary Of General Electric Company) Product Portfolio
9.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Business Performance
9.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Business Development and Market Status
9.8 IBA Group
9.8.1 IBA Group Profiles
9.8.2 IBA Group Product Portfolio
9.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Business Performance
9.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Business Development and Market Status
9.9 Isotec, Inc. (Sigma-Aldrich)
9.9.1 Isotec, Inc. (Sigma-Aldrich) Profiles
9.9.2 Isotec, Inc. (Sigma-Aldrich) Product Portfolio
9.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Business Performance
9.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Business Development and Market Status
9.10 Lantheus Medical Imaging, Inc.
9.10.1 Lantheus Medical Imaging, Inc. Profiles
9.10.2 Lantheus Medical Imaging, Inc. Product Portfolio
9.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Business Performance
9.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Business Development and Market Status
9.11 Nordion, Inc.
9.12 Ntp Radioisotopes (Pty), Ltd.
9.13 Siemens Healthcare (Subsidiary Of Siemens AG)
9.14 Taiyo Nippon Sanso Corporation
9.15 Urenco Limited
9.16 Rotem Industries, Ltd., Inc.
9.17 Australian Nuclear Association And Technology Organization (ANSTO)
9.18 Board of Radiation And Isotope Technology (BRIT)
9.19 Institute of Atomic Energy Polatom Radioisotope Centre
9.20 Institute of Isotopes Co., Ltd.
9.21 Institute Of Radioelement (IRE)
10 World Radiopharmaceuticals in Nuclear Medicine Market Assessment by Players
10.1 Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Players 2014-2020
10.4 Global Radiopharmaceuticals in Nuclear Medicine Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Radiopharmaceuticals in Nuclear Medicine Sales Assessment of Players 2014-2020
11.1.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue Assessment of Players 2014-2020
11.1.3 North America Radiopharmaceuticals in Nuclear Medicine Price Assessment of Players 2014-2020
11.1.4 North America Radiopharmaceuticals in Nuclear Medicine Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales Assessment of Players 2014-2020
11.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Radiopharmaceuticals in Nuclear Medicine Price Assessment of Players 2014-2020
11.2.4 Europe Radiopharmaceuticals in Nuclear Medicine Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Radiopharmaceuticals in Nuclear Medicine Sales Assessment of Players 2014-2020
11.4.2 South America Radiopharmaceuticals in Nuclear Medicine Revenue Assessment of Players 2014-2020
11.4.3 South America Radiopharmaceuticals in Nuclear Medicine Price Assessment of Players 2014-2020
11.4.4 South America Radiopharmaceuticals in Nuclear Medicine Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Countries/Regions 2014-2020
12.2.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries/Regions 2014-2020
12.2.3 North America Radiopharmaceuticals in Nuclear Medicine Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Countries/Regions 2014-2020
12.3.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Countries/Regions 2014-2020
12.3.3 Europe Radiopharmaceuticals in Nuclear Medicine Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Radiopharmaceuticals in Nuclear Medicine Sales by Countries/Regions 2014-2020
12.4.2 South America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries/Regions 2014-2020
12.4.3 South America Radiopharmaceuticals in Nuclear Medicine Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Radiopharmaceuticals in Nuclear Medicine Sales & Revenue Forecast 2021-2026
14.1 World Radiopharmaceuticals in Nuclear Medicine Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Radiopharmaceuticals in Nuclear MedicineSales and Market Share by Regions
14.1.2 World Radiopharmaceuticals in Nuclear MedicineRevenue and Market Share by Regions
15 Asia Radiopharmaceuticals in Nuclear Medicine Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Diagnostic Radiopharmaceuticals
15.1.2 Therapy Radiopharmaceuticals
15.1.3 Enriched Stable Isotopes
15.2 Consumption Forecast by Application, 2021-2026
16 North America Radiopharmaceuticals in Nuclear Medicine Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Diagnostic Radiopharmaceuticals
16.1.2 Therapy Radiopharmaceuticals
16.1.3 Enriched Stable Isotopes
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Diagnostic Radiopharmaceuticals
17.1.2 Therapy Radiopharmaceuticals
17.1.3 Enriched Stable Isotopes
17.2 Consumption Forecast by Application, 2021-2026
18 South America Radiopharmaceuticals in Nuclear Medicine Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Diagnostic Radiopharmaceuticals
18.1.2 Therapy Radiopharmaceuticals
18.1.3 Enriched Stable Isotopes
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Diagnostic Radiopharmaceuticals
19.1.2 Therapy Radiopharmaceuticals
19.1.3 Enriched Stable Isotopes
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) Trend 2021-2026
20.2 Global Radiopharmaceuticals in Nuclear Medicine Gross Profit Trend 2021-2026
21 Conclusion
List of Tables and Figures
Figure Product Picture of Radiopharmaceuticals in Nuclear Medicine
Table Players List in the Report
Table Mergers & Acquisitions, Expansion Plans
Table Global Radiopharmaceuticals in Nuclear Medicine Market Size (Volume) and Growth Rate by Type (2019-2026)
Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application (2019-2026)
Figure Industry Chain Structure of Radiopharmaceuticals in Nuclear Medicine
Table Product Application and Standard
Table Key Suppliers of Raw Material/Components
Figure Industry Chain Structure of Radiopharmaceuticals in Nuclear Medicine
Table Representative Downstream Enterprises of Radiopharmaceuticals in Nuclear Medicine
Figure New Project SWOT Analysis of Radiopharmaceuticals in Nuclear Medicine
Table Industry Policy List of Radiopharmaceuticals in Nuclear Medicine 2019
Table World Radiopharmaceuticals in Nuclear Medicine Sales (Unit) by Type (2014-2020)
Figure World Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) by Type 2014-2020
Table World 2014-2020 Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) by Type
Figure World Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) by Type 2014-2020
Table Diagnostic Radiopharmaceuticals-Sales (K Units), Revenue and Growth Rate
Table Therapy Radiopharmaceuticals-Sales (K Units), Revenue and Growth Rate
Table Enriched Stable Isotopes-Sales (K Units), Revenue and Growth Rate
Table World Enriched Stable Isotopes Revenue (M USD) and Growth Rate
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2014-2020)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2014-2020)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2014-2020)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2014-2020)
Table Key Players in Asia Pacific
Table North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2014-2020)
Figure North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2014-2020)
Table North America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2014-2020)
Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2014-2020)
Table Key Players in North America
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2014-2020)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2014-2020)
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2014-2020)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2014-2020)
Table Key Players in Europe
Table South America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2014-2020)
Figure South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2014-2020)
Table South America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2014-2020)
Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2014-2020)
Table Key Players in South America
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2014-2020)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2014-2020)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2014-2020)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2014-2020)
Table Key Players in Middle East and Africa
Table World Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2014-2020)
Table World Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application (2014-2020)
Table Asia Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2014-2020)
Table Asia Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application (2014-2020)
Table North America Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2014-2020)
Table North America Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application (2014-2020)
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2014-2020)
Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application (2014-2020)
Table South America Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2014-2020)
Table South America Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application (2014-2020)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2014-2020)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application (2014-2020)
Table Bracco Imaging S.P.A. Profiles
Table Bracco Imaging S.P.A. Product Information
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales Market Share 2014-2020
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Cambridge Isotope Laboratories, Inc. Profiles
Table Cambridge Isotope Laboratories, Inc. Product Information
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Market Share 2014-2020
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Cardinal Health, Inc. Profiles
Table Cardinal Health, Inc. Product Information
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Market Share 2014-2020
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Covidien, Plc Profiles
Table Covidien, Plc Product Information
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales Market Share 2014-2020
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Eczacibasi-Monrol Profiles
Table Eczacibasi-Monrol Product Information
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales Market Share 2014-2020
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Fujifilm Holdings Corporation Profiles
Table Fujifilm Holdings Corporation Product Information
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales Market Share 2014-2020
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table GE Healthcare (Subsidiary Of General Electric Company) Profiles
Table GE Healthcare (Subsidiary Of General Electric Company) Product Information
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales Market Share 2014-2020
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table IBA Group Profiles
Table IBA Group Product Information
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Sales Market Share 2014-2020
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Isotec, Inc. (Sigma-Aldrich) Profiles
Table Isotec, Inc. (Sigma-Aldrich) Product Information
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales Middle East and Africa 2014-2020
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Lantheus Medical Imaging, Inc. Profiles
Table Lantheus Medical Imaging, Inc. Product Information
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Middle East and Africa 2014-2020
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Nordion, Inc. Profiles
Table Nordion, Inc. Product Information
Table Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Middle East and Africa 2014-2020
Table Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Ntp Radioisotopes (Pty), Ltd. Profiles
Table Ntp Radioisotopes (Pty), Ltd. Product Information
Table Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales Middle East and Africa 2014-2020
Table Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Siemens Healthcare (Subsidiary Of Siemens AG) Profiles
Table Siemens Healthcare (Subsidiary Of Siemens AG) Product Information
Table Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales Middle East and Africa 2014-2020
Table Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Taiyo Nippon Sanso Corporation Profiles
Table Taiyo Nippon Sanso Corporation Product Information
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales Middle East and Africa 2014-2020
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Urenco Limited Profiles
Table Urenco Limited Product Information
Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales Middle East and Africa 2014-2020
Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Rotem Industries, Ltd., Inc. Profiles
Table Rotem Industries, Ltd., Inc. Product Information
Table Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales Middle East and Africa 2014-2020
Table Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Australian Nuclear Association And Technology Organization (ANSTO) Profiles
Table Australian Nuclear Association And Technology Organization (ANSTO) Product Information
Table Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales Middle East and Africa 2014-2020
Table Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Board of Radiation And Isotope Technology (BRIT) Profiles
Table Board of Radiation And Isotope Technology (BRIT) Product Information
Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales Middle East and Africa 2014-2020
Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Institute of Atomic Energy Polatom Radioisotope Centre Profiles
Table Institute of Atomic Energy Polatom Radioisotope Centre Product Information
Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales Middle East and Africa 2014-2020
Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Institute of Isotopes Co., Ltd. Profiles
Table Institute of Isotopes Co., Ltd. Product Information
Table Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales Middle East and Africa 2014-2020
Table Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Institute Of Radioelement (IRE) Profiles
Table Institute Of Radioelement (IRE) Product Information
Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales Middle East and Africa 2014-2020
Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Sales (Unit) of Players (2014-2020)
Table Sales Share of Players (2014-2020)
Figure World Radiopharmaceuticals in Nuclear Medicine Sales Share in 2019
Table Revenue of Players (2014-2020)
Table Revenue Share of Players (2014-2020)
Figure World Radiopharmaceuticals in Nuclear Medicine Revenue Share in 2019
Table Average Price of Players (2014-2020)
Figure Average Price of Players (2014-2020)
Table Gross Margin of Players (2014-2020)
Figure Gross Margin of Players in 2014
Figure Gross Margin of Players in 2019
Figure World Market Concentration (2014-2019)
Table Top 5 Players Sales Share (2014-2019)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales (Unit) of Players (2014-2019)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Share of Players (2014-2019)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Share in 2019
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue of Players (2014-2019)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Share of Players (2014-2019)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Share in 2019
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Price of Players (2014-2019)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Gross Margin of Players (2014-2019)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Gross Margin Share in 2019
Figure Asia Pacific Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table North America Radiopharmaceuticals in Nuclear Medicine Sales (Unit) of Players (2014-2019)
Table North America Radiopharmaceuticals in Nuclear Medicine Sales Share of Players (2014-2019)
Figure North America Radiopharmaceuticals in Nuclear Medicine Sales Share in 2019
Table North America Radiopharmaceuticals in Nuclear Medicine Revenue of Players (2014-2019)
Table North America Radiopharmaceuticals in Nuclear Medicine Revenue Share of Players (2014-2019)
Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue Share in 2019
Table North America Radiopharmaceuticals in Nuclear Medicine Price of Players (2014-2019)
Table North America Radiopharmaceuticals in Nuclear Medicine Gross Margin of Players (2014-2019)
Figure North America Radiopharmaceuticals in Nuclear Medicine Gross Margin Share in 2019
Figure North America Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales (Unit) of Players (2014-2019)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Share of Players (2014-2019)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Share in 2019
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue of Players (2014-2019)
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue Share of Players (2014-2019)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Share in 2019
Table Europe Radiopharmaceuticals in Nuclear Medicine Price of Players (2014-2019)
Table Europe Radiopharmaceuticals in Nuclear Medicine Gross Margin of Players (2014-2019)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Gross Margin Share in 2019
Figure Europe Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table South America Radiopharmaceuticals in Nuclear Medicine Sales (Unit) of Players (2014-2019)
Table South America Radiopharmaceuticals in Nuclear Medicine Sales Share of Players (2014-2019)
Figure South America Radiopharmaceuticals in Nuclear Medicine Sales Share in 2019
Table South America Radiopharmaceuticals in Nuclear Medicine Revenue of Players (2014-2019)
Table South America Radiopharmaceuticals in Nuclear Medicine Revenue Share of Players (2014-2019)
Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue Share in 2019
Table South America Radiopharmaceuticals in Nuclear Medicine Price of Players (2014-2019)
Table South America Radiopharmace
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
